Molecular Diagnostics
Nanopore-based miRNA Analysis Detects Early Stage Bile Duct Cancer
Bile duct cancer (cholangiocarcinoma) is an often lethal type of cancer, since by the time of diagnosis most bile duct cancers are already incurable. Thus, methods for the early diagnosis of this cancer are urgently needed. Towards this end, a recent paper described a nanopore-based method for detecting microRNA expression patterns characteristic for bile duct cancer. More...29 Jun 2022
Mobile Testing Platform Performs World's Fastest Multiplex PCR and RT-PCR Analysis
A new techniques named hcPCR (high content PCR), combines the advantages of qPCR and dPCR, in order to detect a large number of targets per test (multiplexing) and obtain the maximum amount of information in record time. More...29 Jun 2022
Blood Test to Assess Nerve Damage Could Also Detect Alzheimer’s Years Before Onset
Researchers have identified a protein in the blood that may indicate the degradation of neural connections years before the onset of dementia symptoms. The protein could contribute to the early detection of Alzheimer’s disease and possibly also help to assess nerve damage resulting from stroke or traumatic brain injury. More...28 Jun 2022
Electrochemical Sensor Platform to Enable New Diagnostic Tests in Near-Patient Settings
A novel electrochemical sensor platform will pave the way for the development and commercialization of cost-effective, highly sensitive and specific point-of-care diagnostics for neurological, cardiovascular, and renal diseases. More...28 Jun 2022
First-Ever Blood Test Detects Parkinson’s Disease
To date, there have been neither blood parameters nor imaging examinations to produce a definite diagnosis of Parkinson's disease, let alone early recognition. Now, researchers have developed a method that reliably detects protein changes in blood that are typical of Parkinson's disease. More...24 Jun 2022
Gold Member
Automatic Hematology Analyzer
DH-800 Series
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Sample Transportation System
Tempus1800 Necto
In Other News
Automated Liquid Biopsy Test Detects Advanced Breast Cancer in Five Hours
Blood Test Predicts Likelihood that Nonalcoholic Fatty Liver Disease Will Progress to Liver Cancer
High-Tech Method for Protein Biomarker Assay Testing to Revolutionize POC Diagnosis
Blood Test Detects Unique ‘Fingerprint’ of Early Onset of Diabetic Kidney Disease
Blood Test Can Determine Liver Disease Progression
Metabolism-Based Blood Test to Detect Multiple Cancer Types Prior to Symptoms
Simple Blood Test for Esophageal Cancer Could Reduce Invasive Endoscopy Procedures
Multiviral Pathogen Detection System to Revolutionize Rapid Infectious Disease Diagnosis and Tracking
POC Test Identifies and Differentiates Viral from Bacterial Acute Respiratory Infection in 10 Minutes
Rapid CE-Marked IVD Lung Cancer Test Delivers Results Within Three Hours
PCR System Moves Ultra-Fast Testing From Lab to Patients at Point of Need
Estimated Total Tumor mRNA Predicts Cancer Outcomes
Researchers Describe a Polygenic Risk Score that Predicts Likelihood of Developing Chronic Kidney Disease
Hand-Held Analyzer Provides Critical Sepsis Information in 11 Minutes at POC
AI Tool Merges Patient Data with Blood Test Results to Detect Heart Failure
Simple Blood Test Assesses Prognosis of Advanced Liver Fibrosis in NASH Patients
Liquid Biopsy Assay Predicts if Esophageal Cancer Patients Will Respond to Treatment
Chromosome Instability Patterns Predict Tumor Drug Response
Gene Panel Predicts Likelihood of Favorable Response by Multiple Myeloma Patients to Selinexor Treatment
T-Cell Clinical Test Shortens Time to Accurate Diagnosis of Early Lyme Disease
Recurrent Disease Following DCIS Unrelated to Initial Lesions
Urine Test Distinguishes Between Viral and Bacterial Pneumonia
Serological Biomarker Aids Diagnosis of Rare Kidney Disease Without Biopsy
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
